EUVIMEDEUVIMED entdecken
Crossref

Forward programming of human induced pluripotent stem cells via the ETS variant transcription factor 2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells

Sarah Rieck iD, Kritika Sharma, Carlotta Altringer, Michael Hesse, Christos Triantafyllou, Yanhui Zhang, Volker Busskamp, Bernd K Fleischmann

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Sarah Rieck und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology I, Life & Brain Center, Medical Faculty, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Cell Differentiation, Transcription Factors, Phenotype. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft, DFG, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Endothelial cell (EC) dysfunction plays a key role in the initiation and progression of cardiovascular disease. However, studying these disorders in ECs from patients is challenging; hence, the use of human induced pluripotent stem cells (hiPSCs) and their in vitro differentiation into ECs represents a very promising approach. Still, the generation of hiPSC-derived ECs (hECs) remains demanding as a cocktail of growth factors and an intermediate purification step are required for hEC enrichment. Therefore, we probed the utility of a forward programming approach using transgenic hiPSC lines. Methods and results We have used the transgenic hiPSC line PGP1 ETV2 isoform 2 to explore the in vitro differentiation of hECs via doxycycline-dependent induction of the ETS variant transcription factor 2 (ETV2) and compared these with a standard differentiation protocol for hECs using non-transgenic control hiPSCs. The transgenic hECs were highly enriched without an intermediate purification step and expressed—as non-transgenic hECs and human umbilical vein endothelial cells—characteristic EC markers. The viability and yield of transgenic hECs were strongly improved by applying EC growth medium during differentiation. This protocol was successfully applied in two more transgenic hiPSC lines yielding reproducible results with low line-to-line variability. Transgenic hECs displayed typical functional properties, such as tube formation and LDL uptake, and a more mature phenotype than non-transgenic hECs. Transgenic hiPSCs preferentially differentiated into the arterial lineage; this was further enhanced by adding a high concentration of vascular endothelial growth factor to the medium. We also demonstrate that complexing lentivirus with magnetic nanoparticles and application of a magnetic field enables efficient transduction of transgenic hECs.

Conclusion

We have established a highly efficient, cost-effective, and reproducible differentiation protocol for the generation of functional hECs via forward programming. The transgenic hECs can be genetically modified and are a powerful tool for disease modelling, tissue engineering, and translational purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsCell DifferentiationTranscription FactorsPhenotypeHumansEndothelial CellsHuman Umbilical Vein Endothelial CellsReproducibility of ResultsCost-Benefit AnalysisTime FactorsCell LineCells, CulturedCell SurvivalCellular ReprogrammingCellular Reprogramming Techniques

Stichwörter der Autor:innen

DifferentiationETV2Endothelial cellsForward programmingTranscription factorhiPSCs

Substanzen

Transcription FactorsETV2 protein, human

Autor:innen und Institutionen

  • Institute of Physiology I, Life & Brain Center, Medical Faculty, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
  • Department of Ophthalmology, Medical Faculty, University of Bonn, Bonn, Germany.

ORCID-Profile: Sarah Rieck

Förderung

  • Deutsche Forschungsgemeinschaft
  • DFG
  • German Research Foundation

Zitieren

APA

Rieck, S., Sharma, K., Altringer, C., Hesse, M., Triantafyllou, C., Zhang, Y., Busskamp, V., & Fleischmann, B. K. (2024). Forward programming of human induced pluripotent stem cells via the ETS variant transcription factor 2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae129

Vancouver

Rieck S, Sharma K, Altringer C, Hesse M, Triantafyllou C, Zhang Y, et al. Forward programming of human induced pluripotent stem cells via the ETS variant transcription factor 2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae129

BibTeX
@article{Rieck2024,
  author = {Rieck, Sarah and Sharma, Kritika and Altringer, Carlotta and Hesse, Michael and Triantafyllou, Christos and Zhang, Yanhui and Busskamp, Volker and Fleischmann, Bernd K},
  title = {Forward programming of human induced pluripotent stem cells via the ETS variant transcription factor 2: rapid, reproducible, and cost-effective generation of highly enriched, functional endothelial cells},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae129}
}
Kostenlos starten →